Biophysical characterization of MDR breast cancer cell lines reveals the cytoplasm is critical in determining drug sensitivity

Biochimica et Biophysica Acta - General Subjects

Volumn 1770, Issue 4, 2007, Pages 601-608

  Coley, Helen M ^a   Labeed, Fatima H ^b   Thomas, Hilary ^a   Hughes, Michael P ^b  

^a Postgraduate Medical School   (United Kingdom)

^b UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

Dielectrophoresis; Drug sensitivity; MDR; P gp

Indexed keywords

ANTHRACYCLINE; CISPLATIN; COLCHICINE; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; MITOMYCIN C; PACLITAXEL; TARIQUIDAR; VALSPODAR;

ARTICLE; BREAST CANCER; CELL MEMBRANE CONDUCTANCE; CELL MEMBRANE POTENTIAL; CELL MIGRATION; CONTROLLED STUDY; CYTOPLASM; DRUG ACCUMULATION; DRUG SENSITIVITY; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; ION CONDUCTANCE; ION TRANSPORT; MOLECULAR MECHANICS; MULTIDRUG RESISTANCE; PHENOTYPE; PRIORITY JOURNAL;

ANTHRACYCLINES; ANTINEOPLASTIC AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; BREAST NEOPLASMS; CARBOCYANINES; CELL LINE, TUMOR; CELL SURVIVAL; CISPLATIN; COLCHICINE; CYTOPLASM; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; ELECTROPHORESIS; ETOPOSIDE; FEMALE; FLUORESCENT DYES; HUMANS; INHIBITORY CONCENTRATION 50; MEMBRANE POTENTIALS; MEMBRANE TRANSPORT PROTEINS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; P-GLYCOPROTEIN; PACLITAXEL; PHENOTYPE;

EID: 33847164892     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2006.12.002     Document Type: Article

References (39)

1. Burchenal J.H., and Holmburg E.A.D. The utility of resistant leukaemias in screening for chemotherapeutic activity. Ann. N. Y. Acad. Sci. 76 (1958) 826-829
2. Wadkins R.M., and Roepe P.D. Biophysical aspects of P-glycoprotein-mediated multidrug resistance. Int. Rev. Cytol. 171 (1997) 121-165
3. Roepe P.D., Wei L.Y., Cruz J., and Carlson D. Lowered membrane potential and altered pHi homeostasis in multidrug resistant (MDR) cells: further characterisation of a series of MDR cell lines expressing different levels of P-glycoprotein. Biochemistry 32 (1993) 11042-11056
4. Roepe P.D. The role in the MDR protein in altered drug translocation across tumor cell membranes. Biochim. Biophys. Acta 1241 (1995) 385-406
5. Clarke R., Currier S., Kaplan O., Lovelace E., Boulay V., Gottesman M.M., and Dickson R.B. Effect of P-glycoprotein expression on sensitivity to hormones in MCF-7 human breast cancer cells. J. Natl. Cancer Inst. 84 (1992) 1506-1512
6. Louvet C., Empereur S., Fagot D., Forgue-Lafitte F., Chastre E., Zimber A., Mester J., and Gespach C. The arotinoid Ro 40-8757 has antiproliferative effects in drug-resistant human colon and breast cancer cell lines in vitro. Cancer Lett. 30 (1994) 83-86
7. Hoffman M.M., Wei L.-Y., and Roepe P.D. Are altered pHi and membrane potential in hu MDR1 transfectants sufficient to cause MDR protein-mediated multidrug resistance?. J. Gen. Physiol. 108 (1996) 295-313
8. Pohl H. Dielectrophoresis. 1st ed. (1978), Cambridge Univ. Press, Cambridge
9. Jones T.B. Electromechanics of Particles (1995), Cambridge Univ. Press, Cambridge
10. Hughes M.P. Nanoelectromechanics in Engineering and Biology. 1st ed. (2002), CRC Press, Boca Raton
11. Burt J.P.H., Pethig R., Gascoyne P.R.C., and Becker F.F. Dielectrophoretic characterization of Friend murine erythroleukaemic cells as a measure of induced differentiation. Biochim. Biophys. Acta 1034 (1990) 93-101
12. Gascoyne P.R.C., Huang Y., Pethig R., Vykoukal J., and Becker F.F. Dielectrophoretic separation of mammalian-cells studied by computerized image-analysis. Meas. Sci. Technol. 3 (1992) 439-445
13. Gascoyne P.R.C., Pethig R., Burt J.P.H., and Becker F.F. Membrane changes accompanying the induced-differentiation of Friend murine erythroleukemia-cells studied by dielectrophoresis. Biochim. Biophys. Acta 1149 (1993) 119-126
14. Gascoyne P.R.C., Wang X.B., Huang Y., and Becker F.F. Dielectrophoretic separation of cancer cells from blood. IEEE Trans. Ind. Appl. 33 (1997) 670-678
15. Becker F.F., Wang X.B., Huang Y., Pethig R., Vykoukal J., and Gascoyne P.R.C. The removal of human leukemia-cells from blood using interdigitated microelectrodes. J. Phys. D: Appl. Phys. 27 (1994) 2659-2662
16. Stephens M., Talary M.S., Pethig R., Burnett A.K., and Mills K.I. The dielectrophoresis enrichment of CD34(+) cells from peripheral blood stem cell harvests. Bone Marrow Transplant. 18 (1996) 777-782
17. Wang X.J., Yang J., and Gascoyne P.R.C. Role of peroxide in AC electrical field exposure effects on Friend murine erythroleukemia cells during dielectrophoretic manipulations. Biochim. Biophys. Acta 1426 (1999) 53-68
18. Cristofanilli M., De Gasperis G., Zhang L.S., Hung M.C., Gascoyne P.R.C., and Hortobagyi G.N. Automated electrorotation to reveal dielectric variations related to HER-2/neu overexpression in MCF-7 sublines. Clin. Cancer Res. 8 (2002) 615-619
19. Labeed F.H., Coley H.M., Thomas H., and Hughes M.P. Assessment of multidrug resistance reversal using dielectrophoresis and flow cytometry. Biophys. J. 85 (2003) 2028-2034
20. Leonessa F., Jacobson M., Boyle B., Lippman J., McGarvey M., and Clarke R. Effect of tamoxifen on the multidrug resistant phenotype in human breast cancer cells: isobologram, drug accumulation and M(r) 170,000 glycoprotein (gp170) binding studies. Cancer Res. 54 (1994) 441-447
21. Mosmann T. Rapid colorimetric assay for cellular growth and survival-application to proliferation and cytotoxicity assays. J. Immunol. Methods 65 (1983) 55-63
22. Mistry P., Stewart A.J., and Dangerfield W. In vitro and in vivo reversal of P-glycoprotein mediated multidrug resistance by a novel potent modulator, XR9576. Cancer Res. 61 (2001) 749-758
23. Yanagisawa T., Newman A., Coley H.M., Renshaw J., Pinkerton C.R., and Pritchard-Jones K. BIRICODAR (VX-710; Incel): an effective chemosensitizer in neuroblastoma. Br. J. Cancer 80 (1999) 1190-1196
24. Broche L., Labeed F.H., and Hughes M.P. Extraction of dielectric properties for multiple populations from dielectrophoretic collection spectrum data. Phys. Med. Biol. 50 (2005) 2267-2274
25. Gimsa J., Schnelle T., Zechel G., and Glaser R. Dielectric spectroscopy of human erythrocytes: investigations under the influence of nystatin. Biophys. J. 66 (1994) 1244-1253
26. Huisman M.T., Chhatta A.A., van Tellingen O., Beijnen J.H., and Schinkel A.H. MRP2 (ABCC2) transports taxanes and confers paclitaxel resistance and both processes are stimulated by probenecid. Int. J. Cancer 116 (2005) 824-829
27. Deeley R.G., Westlake C., and Cole S.P.C. Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins. Physiol. Rev. 86 (2006) 849-899
28. Gollapudi S., and Gupta S. Lack of reversal of daunorubicin resistance in HL-60AR cells by cyclosporine A. Anticancer Res. 12 (1992) 2127-2132
29. Vayuvegula B., Slater L., Meador J., and Gupta S. Correction of altered plasma membrane potentials-A possible mechanism of cyclosporine A and verapamil reversal of pleiotropic drug resistance in neoplasia. Cancer Chemother. Pharmacol. 22 (1988) 163-168
30. Gong Y., Duvvuri M., Duncan M., Liu J., and Krise J.P. Niemann-Pick C1 protein facilitates the efflux of the anticancer drug daunorubicin from cells according to a novel vesicle mediated pathway. J. Pharmacol. Exp. Ther. 316 (2006) 242-247
31. Kipp H., and Arias I.M. Intracellular trafficking and regulation of canalicular ATP-binding cassette transporters. Semin. Liver Dis. 20 (2000) 339-351
32. Aleman C., Annereau J.-P., Liang X.-J., Cardarelli C.O., Taylor B., Yin J.J., Aszalos A., and Gottesman M.M. P-glycoprotein expressed in multidrug resistant cells is not responsible for alterations in membrane fluidity or membrane potential. Cancer Res. 63 (2003) 3084-3091
33. Luker G.D., Flagg T.P., Sha Q., Luker K.E., Pica C.M., Nichols C.G., and Piwinica-Worms D. MDR1 P-glycoprotein reduces influx of substrates without affecting membrane potentials. J. Biol. Chem. 276 (2001) 49053-49060
34. Pethig R., and Kell D.B. The passive electrical properties of biological systems: their significance in physiology, biophysics and biotechnology. Phys. Med. Biol. 32 (1987) 933-970
35. 2+and protein kinase C via distinct mechanisms. EMBO J. 17 (1998) 4340-4345
36. Belhoussine R., Morjani H., Sharonov S., Ploton D., and Manfait M. Characterisation of intracellular pH gradients in human multidrug resistant tumour cells by means of scanning microspectrofluorometry and dual emission ratio probes. Int. J. Cancer 81 (1999) 81-89
37. Raghunand N., Martinez-Zaguilan R., Wright S.H., and Gillies R.J. pH and drug resistance. II Turnover of acidic vesicles and resistance to weakly basic chemotherapeutic drugs. Biochem. Pharmacol. 57 (1999) 1047-1058
38. Ringel I., and Horwitz S.B. Effect of alkaline pH on Taxol-microtubule interactions. J. Pharmacol. Exp. Ther. 259 (1991) 855-860
39. Mukhopadhyay K., Parak P.K., and Battacharyya B. The carboxy terminus of the alpha subunit of tubulin regulates its interaction with colchicine. Biochemistry 29 (1990) 6845-6850